Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 10Plasma cell 3Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 300Fluorouracil 272Gemcitabine 236Bevacizumab 235Leucovorin 211Capecitabine 207pembrolizumab 201Nivolumab 158Irinotecan 158Cisplatin 150Specimen Handling 143Magnetic Resonance Spectroscopy 129130-nm albumin-bound paclitaxel 118Paclitaxel 109durvalumab 106Cetuximab 103Radiotherapy 99Drug Therapy 94atezolizumab 93Biopsy 92tislelizumab 81Albumin-Bound Paclitaxel 81Taxes 74lenvatinib 67Folfox protocol 67Carboplatin 66regorafenib 60Blood Specimen Collection 60sintilimab 54Ipilimumab 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
apixaban × Gastrointestinal × 1 year × Clear all
NCT07132515 2025-08-20

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Mansoura University

Phase 4 Recruiting
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡